Concepedia

Jennifer Koenitzer

JK

5

Publications

235

Citations

5

H-Index

2013

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Boehringer Ingelheim (Germany)

Jennifer Koenitzer is an author at Bristol-Myers Squibb (United States) specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

2013–2023

5

Publications

5

Stable microRNA expression enhances therapeutic antibody productivity of Chinese hamster ovary cells

Michaela Strotbek, Lore Florin, Jennifer Koenitzer et al. · Metabolic Engineering · 2013 · 78 citations · Full text

, , +14

Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor

Dan You, Stephen Hillerman, Gregory Locke et al. · Journal for ImmunoTherapy of Cancer · 2021 · 75 citations · Full text

Interrogating the immune-modulating roles of radiation therapy for a rational combination with immune-checkpoint inhibitors in treating pancreatic cancer

Kenji Fujiwara, May Tun Saung, Hao Jing et al. · Journal for ImmunoTherapy of Cancer · 2020 · 35 citations · Full text

, , +20

Stability of single copy transgene expression in CHOK1 cells is affected by histone modifications but not by DNA methylation

Shawal Spencer, Agustina Gugliotta, Jennifer Koenitzer et al. · Journal of Biotechnology · 2014 · 31 citations · Full text

, , +10

Comprehensive immunophenotyping of solid tumor-infiltrating immune cells reveals the expression characteristics of LAG-3 and its ligands

Bradley Garman, Can Jiang, Sherif Daouti et al. · Frontiers in Immunology · 2023 · 16 citations · Full text

Rows per page

1–5 of 5